Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-023799
Filing Date
2025-03-14
Accepted
2025-03-13 18:11:50
Documents
109
Period of Report
2025-01-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0233977-10q_rafael.htm   iXBRL 10-Q 1840664
2 CERTIFICATION ea023397701ex31-1_rafael.htm EX-31.1 9711
3 CERTIFICATION ea023397701ex31-2_rafael.htm EX-31.2 9729
4 CERTIFICATION ea023397701ex32-1_rafael.htm EX-32.1 4332
5 CERTIFICATION ea023397701ex32-2_rafael.htm EX-32.2 4322
  Complete submission text file 0001213900-25-023799.txt   11604037

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE rfl-20250131.xsd EX-101.SCH 112387
7 XBRL CALCULATION FILE rfl-20250131_cal.xml EX-101.CAL 87891
8 XBRL DEFINITION FILE rfl-20250131_def.xml EX-101.DEF 554244
9 XBRL LABEL FILE rfl-20250131_lab.xml EX-101.LAB 965306
10 XBRL PRESENTATION FILE rfl-20250131_pre.xml EX-101.PRE 579755
111 EXTRACTED XBRL INSTANCE DOCUMENT ea0233977-10q_rafael_htm.xml XML 1509543
Mailing Address 520 BROAD STREET NEWARK NJ 07120
Business Address 520 BROAD STREET NEWARK NJ 07120 212-658-1450
Rafael Holdings, Inc. (Filer) CIK: 0001713863 (see all company filings)

EIN.: 822296593 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-38411 | Film No.: 25737134
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)